Stockreport

Syndax Pharmaceuticals (SNDX): Assessing Value After Revuforj FDA Expansion and Revenue Surge [Yahoo! Finance]

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com
PDF This development has sparked new interest among investors. See our latest analysis for Syndax Pharmaceuticals. Syndax Pharmaceuticals' strong Q3 numbers and Revuforj [Read more]